Private Equity Videos
newest 100 private equity videos / private equity widgets / media rss:

On the distressed investing panel at The Deal's Fifth Annual Private Capital Symposium Raquel Palmer, a partner at KPS Special Situations, talked about how the distressed opportunities are unfolding differently in the current cycle than in prior downturns.For more check out www.thedeal.com/blogs

Kenneth D. Moelis, Chief Executive Officer, Moelis & Co., was the first keynote interview at the The Deal's Fifth Annual Private Capital Symposium, May 15, 2008. "I think the cycle in the late 1980s and the current one were very similiar," Moelis said. "There was a tremendous amount of liquidity in the 1980s, and deal multiples did get driven into excess. But they were restricted to one firm, so when the crisis hit it was restricted to one firm, Drexel." For complete coverage, visit TheDeal.com for live updates from the event.

TheDeal.com breaks down the essential M&A happeninga for the week of May 5th, including a preview of the Clear Channel/Bain/TH Lee trial, News Corp's earnings, the Getty Images deal and more.Tune into The Deal calendar every week to plan your schedule.

BusinessWeek's John Byrne and Emily Thornton discuss how Phil Falcone and his fellow scavengers just might kick-start the economy

Jonathan Korngold, Managing Director at General Atlantic LLC, discussed international investments in healthcare at The Deal's Healthcare Dealmaking Symposium. Korngold works closely with the firm's public and private portfolio companies and is currently a Board member of Emdeon Business Services. Prior to joining General Atlantic, Korngold was a member of Goldman Sachs s Principal Investment Area and Mergers & Acquisitions groups in London and New York. Korngold received his M.B.A. from Harvard Business School and graduated with a B.A. in Economics with Honors from Harvard College.

Chris Gordon is a Principal at Bain Capital. Gordon spoke about the acquisition of Quintiles at The Deal's Healthcare Dealmaking Symposium. Some of his transaction experiences include Warner Chilcott, Accellent, CRC Health Group and Epoch Senior Living. Gordon is also a member of the board of directors for CRC Health Group. Prior to joining Bain Capital, Gordon was a consultant at Bain & Company. Gordon received an MBA from Harvard Business School where he was a Baker Scholar and graduated magna cum laude with an AB in Economics from Harvard College. See more video from Healthcare Dealmaking Symposium

John Leone, a partner at Paul Capital Partners appeared at The Deal's Healthcare Dealmaking Symposium to discuss investment in the intellectual properties of universities and small companies. Prior to joining Paul Captial Healthcare Leone was president and Chief Executive Officer of Cambrex Corporation. He also served as Senior Vice President and Chief Operating Officer of US Commercial Operations at Aventis. He received his BS degree in Engineering from the US Military Academy at West Point and his MBA from the University of Colorado.For more on this conference visit The Deal.

In this clip Benjamin Edmands, managing director of CCMP Capital Advisors , outlines challenges, trends, and investment strategies within healthcare in order to answer a question from Michael Kaplan, Managing Director, Health Care Team Leader at Standard & Poor. See more at The Deal.com.

From the panel, Private Equity and the Healthcare M A Market: What s on the Radar? comes this podcast featuring the panelists Benjamin Edmands, managing director, CCMP Capital; Jonathan Korngold, managing director, global head of healthcare, General Atlantic; Todd Richter, managing director, global healthcare group, head of financial sponsor coverage transaction development, Bank of America; and Nathaniel Zilkha, principal, Kohlberg Kravis Roberts. The panel is part of the The Deal s Healthcare Dealmaking Symposium. Tags: Private Equity, Healthcare M A, Benjamin Edmands, CCMP Capital, Jonathan Korngold, General Atlantic, Todd Richter, Bank of America, Nathaniel Zilkha, Kohlberg Kravis Roberts, The Deal, Healthcare Dealmaking Symposium

Charles Ditkoff is managing director and co-head of the global healthcare services group with Banc of America Securities. In this podcast, from the Healthcare Dealmaking Symposium hosted by The Deal in New York City, Ditkoff speaks with PodTech s Jason Lopez about the state of I.T. in the medical industry. Ditkoff participated in the symposium s panel discussion, Market Spotlight: Healthcare Technology Deals on the Rise? Health care technology continues to attract capital, raking in the majority of dollars invested in health care mergers and acquisitions. With billion-dollar deals on the decline, there is equal opportunity for strategics and private equity in the health care technology segment. Tags: Charles Ditkoff, Healthcare Dealmaking Symposium, The Deal, Jason Lopez, Health care, private equity, health care technology

Join BearingPoint Senior Manager Kirsten Trusko to explore consumer-directed health care and how it is affecting the mergers and acquisitions market. A rush of M A activity is under way at the convergence of the banking, insurance and health industries. Companies in all three areas, as well as private equity and venture capital firms, are looking to capitalize on the market dynamics emerging with the growth of consumer-directed health care and the emerging vertical market of health banking. While the complexities of cross-industry M A are even greater than those for intra-industry transactions, the similarities between the industries contribute to a compelling business case. The key is a deep understanding of market direction and growth, a well-planned approach to the transaction and, equally important, clear confidence as to what happens post-transaction, both inside the company and in the marketplace. The convergence of banking, insurance and health is driving great opportunity to leverage strengths, capabilities and channels across market sectors to the benefit of consumers, companies and investors. But the risk of disappointing outcomes is especially high in inter-industry efforts without essential knowledge and planning. To improve the chances of a positive outcome, look well beyond the deep financial analysis applied to traditional intra-industry efforts. Finally, design and articulate a post-transaction operating model that can position you to take advantage of this dramatic U.S. economic shift. Tags: BearingPoint, Kirsten Trusko, consumer-directed, mergers and acquisitions, M A, private equity, venture capital, health banking, CDH

In 2008's turbulent market, do you spread your investments across a range of asset classes, or keep faith in stocks and shares? Seven Investment's Justin Urquhart Stewart shares his top tips.

Is India's Tata the Right Buyer for Jaguar, Investing in Clean Tech

It was a year of two halves: Maynard Paton and David Stevenson reflect on 2007's winners and losers. Plus, as the economic outlook becomes decidedly gloomier, David Kuo asks what the market has in store for investors in 2008.

The Carlyle Group's David Rubenstein discusses private equity firms going public.

Carlyle Group's David Rubenstein discusses how the buyout market will bounce back. For more on Rubenstein's comments, read Dealscape.TheDealBlogs.com.

More from Bruce Wasserstein, Chairman and CEO of Lazard and Chairman of Wasserstein & Co., at The Deal's M&A Outlook 2008 event. For complete coverage, read TheDealBlogs.com.

Bruce Wasserstein, Chairman and CEO of Lazard and also Chairman of Wasserstein & Co. and The Deal LLC, at the M&A Outlook 2008 conference. For more from M&A Outlook 2008, read TheDealBlogs.com.

Leon Black, founder of Apollo Advisors, L.P., offers his assessment of the subprime mortgage meltdown and how it has impacted dealmaking. Read TheDealBlogs.com for more on Black's comments.

Martin Lipton, founding partner of Wachtell, Lipton, Rosen & Katz, discusses the role of sovereign wealth funds and the current state of dealmaking activity. Read more details on Lipton's appearance at M&A Outlook 2008.

BusinessWeek's John Byrne and Emily Thornton say that for CEOs of private-equity-owned companies, the pressure to deliver is getting unbearably intense

Whenever catastrophic environmental change takes place, species are forced to adapt to survive. Under the pressure of globalization and regulations like Sarbanes–Oxley, the corporate environment is undergoing drastic change, too. Chief Financial Officers (CFOs) no longer can serve merely as tactical stewards of their companies or settle for crunching numbers.

BusinessWeek Executive Editor John Byrne talks with Senior Writer Emily Thornton about how, with Wall Street watching, Clayton Dubilier salvaged the Home Depot buyout--and showed how other big deals in the works can go forward

The best and brightest have been humbled in the late summer’s brutal credit crunch: KKR Financial. Blackstone. Goldman Sachs, the black-box quant funds. BusinessWeek Executive Editor John Byrne and Wall Street writer Roben Farzad talk about how we got here

BusinessWeek's weekly podcast features the magazine's writers and editors recapping the week's top business and economic stories, as well as taking an advance look at the most important economic news expected in the week ahead